CEL plans 35 MW of geothermal expansion in El Salvador - ThinkGeoEnergy Geothermal Energy News - 09 Nov 2022 CEL plans 35 MW of geothermal expansion in El Salvador ... More
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy | Blood ... Nature - 09 Aug 2023 Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy | Blood ... ... More
CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA PR Newswire - 18 Oct 2022 CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA ... More
Celsius Token Holders Lose Bid to Hike CEL Valuation CoinDesk - 25 Aug 2023 Celsius Token Holders Lose Bid to Hike CEL Valuation ... More
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting ... ScienceDirect.com - 19 Jan 2023 Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting ... ... More
Market Cool On CEL Corporation's (TSE:5078) Revenues simplywall.st - 25 Mar 2024 Market Cool On CEL Corporation's (TSE:5078) Revenues ... More
Acalabrutinib/Axi-Cel Generates Preliminary Responses in Relapsed/Refractory B-Cell Lymphoma OncLive - 22 Feb 2024 Acalabrutinib/Axi-Cel Generates Preliminary Responses in Relapsed/Refractory B-Cell Lymphoma ... More
Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet Yahoo Finance - 27 Mar 2024 Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet ... More
Axi-Cel Improves Survival Vs SOC in Relapsed/Refractory LBCL Cancer Network - 06 Jun 2023 Axi-Cel Improves Survival Vs SOC in Relapsed/Refractory LBCL ... More
New Standard GB-18613-2020 for Electric Motor CEL Certifications MPR China Certification GmbH - 19 Aug 2021 New Standard GB-18613-2020 for Electric Motor CEL Certifications ... More
First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results Clinical Trials Arena - 03 Aug 2023 First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results ... More
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD HCPLive - 06 Mar 2024 The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD ... More
Relma-Cel Continues to Elicit Responses in Chinese Patients With R/R Mantle Cell Lymphoma OncLive - 19 Dec 2023 Relma-Cel Continues to Elicit Responses in Chinese Patients With R/R Mantle Cell Lymphoma ... More
Statutory Profit Doesn't Reflect How Good CEL's (TSE:5078) Earnings Are Simply Wall St - 19 Apr 2024 Statutory Profit Doesn't Reflect How Good CEL's (TSE:5078) Earnings Are ... More
Afami-cel provides a novel treatment option for rare sarcoma subtypes Nature - 18 Apr 2024 Afami-cel provides a novel treatment option for rare sarcoma subtypes ... More
FDA Approval Sought for Obe-Cel in Relapsed/Refractory B-ALL OncLive - 27 Nov 2023 FDA Approval Sought for Obe-Cel in Relapsed/Refractory B-ALL ... More
FDA Grants Priority Review to Expand Liso-Cel Indications in R/R Follicular Lymphoma and MCL OncLive - 30 Jan 2024 FDA Grants Priority Review to Expand Liso-Cel Indications in R/R Follicular Lymphoma and MCL ... More
FELIX Pooled Analysis Findings Potentiate Further Obe-Cel Development in B-ALL OncLive - 12 Feb 2024 FELIX Pooled Analysis Findings Potentiate Further Obe-Cel Development in B-ALL ... More